Disney Taps Parks Chief Josh D’Amaro to Succeed Iger as CEO

Disney Taps Parks Chief Josh D’Amaro to Succeed Iger as CEO

Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.

Market news and in-depth company research.

Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu

- Geetha Ranganathan, Bloomberg Intelligence Analyst, discusses Walt Disney saying Josh D’Amaro will succeed Bob Iger as chief executive officer of the entertainment giant. D’Amaro, a 28-year-veteran of Disney, will succeed Iger effective March 18, the Burbank, California-based company said Tuesday in a statement. Iger will stay on the board and serve as a senior adviser until his retirement on Dec. 31.

- Diksha Gera, Bloomberg Intelligence Global Fintech and Payments Analyst, discusses Paypal earnings. PayPal Holdings said HP Chief Executive Officer Enrique Lores will take the top job from Alex Chriss, whose turnaround plan failed to meet targets.

- Ken Shea, Bloomberg Intelligence Senior Consumer Products Analyst, discusses PepsiCo earnings. PepsiCo Inc. is cutting prices by as much as 15% for key brands, including Lay’s and Doritos, to lift sales by offering more affordable products.

- Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses Pfizer earnings. Pfizer revealed data from one of its new obesity treatments early Tuesday with little detail, leaving investors wondering if the up to $10 billion it spent purchasing the company that created the medicine will pay off.

See omnystudio.com/listener for privacy information.

Avsnitt(3329)

ZICO Founder Rampolla on New Book: 'High-Hanging Fruit' (Audio)

ZICO Founder Rampolla on New Book: 'High-Hanging Fruit' (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Mark Rampolla, Founder and former CEO of ZICO Coconut Water, on his new book, "High-Hanging Fruit" about giving consumers a quality ...

19 Juli 20168min

IVA's de Vaulx Likes Astellas Pharma: A Great Bargain (Audio)

IVA's de Vaulx Likes Astellas Pharma: A Great Bargain (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Charles de Vaulx, CIO of International Value Advisers (IVA), with a macro look at gold, equities - and the stocks he favors.See omny...

18 Juli 201611min

George Shultz: War and Religion Are Joined, Need to Adapt (Aud)

George Shultz: War and Religion Are Joined, Need to Adapt (Aud)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Former Secretary of State George Shultz, Distinguished Fellow at the Hoover Institution, on the US election and his new book, "Bluep...

18 Juli 201611min

Bloomberg's Sweeney on Netflix EPS: Slowdown in New Subs(Audio)

Bloomberg's Sweeney on Netflix EPS: Slowdown in New Subs(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Paul Sweeney, Director of North American Research and Media analyst for Bloomberg Intelligence, on Netflix's earnings miss, and a Ya...

18 Juli 20168min

Bloomberg's Wilson on Winners, Losers, Stock of the Day (Audio)

Bloomberg's Wilson on Winners, Losers, Stock of the Day (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Bloomberg stocks editor David Wilson on today's market winners, losers, and Stock of the Day: Wesco Aircraft Holdings (WAIR).See omn...

18 Juli 201612min

BlueStar's Schoenfeld: Israeli Stocks Leading Tech Rally(Audio)

BlueStar's Schoenfeld: Israeli Stocks Leading Tech Rally(Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010Guest:\u0010Steven Schoenfeld, CIO of BlueStar Indexes, on why Israeli tech stocks are leading the tech rally.See omnystudio.com...

18 Juli 20166min

Bloomberg's Bender on RNC Convention Lacking Excitement (Audio)

Bloomberg's Bender on RNC Convention Lacking Excitement (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Michael Bender, Senior US Politics reporter for Bloomberg, in Cleveland for a look at the Republican National Convention.See omnystu...

18 Juli 201611min

Amicus' Crowley on Expanding Pipeline for Rare Diseases (Audio)

Amicus' Crowley on Expanding Pipeline for Rare Diseases (Audio)

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: HEALTHCARE: John Crowley, CEO of Amicus Therapeutics, on expanding its pipeline of treatments for rare and orphan diseases.See omnys...

18 Juli 20168min

Populärt inom Business & ekonomi

badfluence
framgangspodden
rss-jossan-nina
varvet
uppgang-och-fall
bathina-en-podcast
avanzapodden
svd-tech-brief
rss-kort-lang-analyspodden-fran-di
rss-borsens-finest
rss-inga-dumma-fragor-om-pengar
borsmorgon
24fragor
lastbilspodden
kapitalet-en-podd-om-ekonomi
dynastin
rss-dagen-med-di
rss-den-nya-ekonomin
market-makers
fill-or-kill